Guardian Pharmacy Services (GRDN) EBIT (2023 - 2026)

Guardian Pharmacy Services has disclosed EBIT across 4 years of filings, most recently posting $17.7 million for Q1 2026.

• EBIT for Q1 2026 came in at $17.7 million, up 35.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $77.4 million (up 233.75% YoY), and the FY2025 annual result was $72.7 million, up 215.55% from the prior year.
• EBIT came in at $17.7 million for Q1 2026 at Guardian Pharmacy Services, down from $30.8 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $30.8 million in Q4 2025 to a low of -$104.6 million in Q3 2024.
• The 4-year median for EBIT is $15.5 million (2023), against an average of $3.3 million.
• Across the five-year window, EBIT tumbled 1552.65% in 2024 and surged 115.63% in 2025, its largest moves.
• Guardian Pharmacy Services' EBIT stood at $15.5 million in 2023, then advanced by 7.93% to $16.8 million in 2024, then surged by 83.6% to $30.8 million in 2025, then sank by 42.54% to $17.7 million in 2026.
• The last three EBIT figures came in at $17.7 million (Q1 2026), $30.8 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.